Celularity (CELU) Net Margin (2020 - 2026)
Celularity (CELU) recorded Net Margin of 10.05% in Q2 2026, up 437.60 percentage points from -427.55% a year earlier but down 7.50 percentage points from the prior quarter.
Celularity (CELU) Net Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Celularity's Net Margin came in at -247.72% as of Jun 30, 2026, down 82.36 percentage points year-over-year; for FY2025, it came in at -345.76%, down 238.99 percentage points from FY2024.
- Annual Net Margin has a five-year change of +1112.66 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -106.77% in FY2024 (+755.27 pp), -862.04% in FY2023 (-940.99 pp), 78.95% in FY2022 (+548.22 pp) and -469.27% in FY2021 (+989.15 pp).
- Quarterly Net Margin has ranged from -2479.56% in Q3 2023 to 1266.58% in Q2 2022 over the past five years.
- On a year-over-year basis, Net Margin rose in three of the last eight quarters, with an average year-over-year change of +200.12 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 3283.38 percentage points in Q2 2022, against a drop of 2898.61 percentage points in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 17.55% (Q1 2026), -594.23% (Q4 2025) and -436.66% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | -1.65% |
| 10 | Celularity | 30.75 Mn | 23.50 Mn | 3.09 Mn | 10.05% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.05% |
| Mar 31, 2026 | 17.55% |
| Dec 31, 2025 | -594.23% |
| Sep 30, 2025 | -436.66% |
| Jun 30, 2025 | -427.60% |
| Mar 31, 2025 | -173.45% |
| Dec 31, 2024 | -73.30% |
| Sep 30, 2024 | -173.19% |
| Jun 30, 2024 | -53.57% |
| Mar 31, 2024 | -149.94% |
| Dec 31, 2023 | 78.82% |
| Sep 30, 2023 | -2,479.56% |
| Jun 30, 2023 | -1,632.03% |
| Mar 31, 2023 | -1,626.86% |
| Dec 31, 2022 | 591.77% |
| Sep 30, 2022 | 116.06% |
| Jun 30, 2022 | 1,266.58% |
| Mar 31, 2022 | -1,059.26% |
| Dec 31, 2021 | -83.20% |
| Sep 30, 2021 | 470.14% |
Celularity Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CELU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();